The DOI matches its Crossref record; 126 of the 126 references it cites were found in a registry or an index.
Natural Products/Bioactive Compounds as a Source of Anticancer Drugs
Open accessAbstract
Cancer is one of the major deadly diseases globally. The alarming rise in the mortality rate due to this disease attracks attention towards discovering potent anticancer agents to overcome its mortality rate. The discovery of novel and effective anticancer agents from natural sources has been the main point of interest in pharmaceutical research because of attractive natural therapeutic agents with an immense chemical diversity in species of animals, plants, and microorganisms. More than 60% of contemporary anticancer drugs, in one form or another, have originated from natural sources. Plants and microbial species are chosen based on their composition, ecology, phytochemical, and ethnopharmacological properties. Plants and their derivatives have played a significant role in producing effective anticancer agents. Some plant derivatives include vincristine, vinblastine, irinotecan, topotecan, etoposide, podophyllotoxin, and paclitaxel. Based on their particular activity, a number of other plant-derived bioactive compounds are in the clinical development phase against cancer, such as gimatecan, elomotecan, etc. Additionally, the conjugation of natural compounds with anti-cancerous drugs, or some polymeric carriers particularly targeted to epitopes on the site of interest to tumors, can generate effective targeted treatment therapies. Cognizance from such pharmaceutical research studies would yield alternative drug development strategies through natural sources which could be economical, more reliable, and safe to use.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED: Resveratrol eliminates cancer stem cells of osteosarcoma by STAT3 pathway inhibition
Peng, L., & Jiang, D. (2018) · PLoS ONE · doi:10.1371/journal.pone.0205918 · Cited by 92
RetractedMicrotubules as a target for anticancer drugs
Jordan, M. A., & Wilson, L. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1317 · Cited by 4,000
Camptothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase I.
Hsiang, Y. H., Hertzberg, R., Hecht, S., & Liu, L. F. (1985) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)38654-4 · Cited by 2,362
Medicinal mushrooms as a source of antitumor and immunomodulating polysaccharides
S., W. (2002) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-002-1076-7 · Cited by 2,141
Plants as a source of anti-cancer agents
Cragg, G. M., & Newman, D. J. (2005) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2005.05.011 · Cited by 2,034
Wilken, R., Veena, M. S., Wang, M. B., & Srivatsan, E. S. (2011) · Molecular Cancer · doi:10.1186/1476-4598-10-12 · Cited by 1,066
Screening of some Indian medicinal plants for their antimicrobial properties
Ahmad, I., Mehmood, Z., & Mohammad, F. (1998) · Journal of Ethnopharmacology · doi:10.1016/s0378-8741(98)00055-5 · Cited by 1,015
Pisha, E., Chai, H., Lee, I.-S., Chagwedera, T. E., Farnsworth, N. R., Cordell, G. A., Beecher, C. W. W., Fong, H. H. S., Kinghorn, A. D., Brown, D. M., et al. (1995) · Nature Medicine · doi:10.1038/nm1095-1046 · Cited by 886
Anand, U., Jacobo-Herrera, N., Altemimi, A., & Lakhssassi, N. (2019) · Metabolites · doi:10.3390/metabo9110258 · Cited by 867
Recent Advances in Chemoprevention of Cancer
Hong, W. K., & Sporn, M. B. (1997) · Science · doi:10.1126/science.278.5340.1073 · Cited by 827
Wasser, S. P., & Weis, A. L. (1999) · International Journal of Medicinal Mushrooms · doi:10.1615/intjmedmushrooms.v1.i1.30 · Cited by 808
Therapeutic Effects of Substances Occurring in Higher Basidiomycetes Mushrooms: A Modern Perspective
Weis, A. L., & Wasser, S. P. (1999) · Critical Reviews™ in Immunology · doi:10.1615/critrevimmunol.v19.i1.30 · Cited by 770
Flavopiridol Inactivates P-TEFb and Blocks Most RNA Polymerase II Transcription in Vivo
Chao, S.-H., & Price, D. H. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m102306200 · Cited by 621
Mechanism of inhibition of cell proliferation by Vinca alkaloids.
Jordan, M. A., Thrower, D., & Wilson, L. (1991) · PubMed · Cited by 534
Prodrug Strategies in Anticancer Chemotherapy
Kratz, F., Müller, I. A., Ryppa, C., & Warnecke, A. (2008) · ChemMedChem · doi:10.1002/cmdc.200700159 · Cited by 486
Medicinal mushroom modulators of molecular targets as cancer therapeutics
Zaidman, B.-Z., Yassin, M., Mahajna, J., & Wasser, S. P. (2005) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-004-1787-z · Cited by 434
Plant-based anticancer molecules: A chemical and biological profile of some important leads
Srivastava, V., Negi, A., Kumar, J. K., Gupta, M. M., & Khanuja, S. P. S. (2005) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2005.05.066 · Cited by 379
Transport of paclitaxel (Taxol) across the blood-brain barrier in vitro and in vivo
Fellner, S., Bauer, B., Miller, D. S., Schaffrik, M., Fankhänel, M., Spruß, T., Bernhardt, G., Graeff, C., Färber, L., Gschaidmeier, H., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15451 · Cited by 359
Camptothecin and Taxol: Historic Achievements in Natural Products Research
Oberlies, N. H., & Kroll, D. J. (2004) · Journal of Natural Products · doi:10.1021/np030498t · Cited by 353
Imbert, T. F. (1998) · Biochimie · doi:10.1016/s0300-9084(98)80004-7 · Cited by 350
Bissery, M.-C., Nohynek, G., Sanderink, G.-J., & Lavelie, F. (1995) · Anti-Cancer Drugs · doi:10.1097/00001813-199506000-00001 · Cited by 323
A Critical Review on Health Promoting Benefits of Edible Mushrooms through Gut Microbiota
Jayachandran, M., Xiao, J., & Xu, B. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18091934 · Cited by 294
CURCUMA LONGA AND CURCUMIN: A REVIEW ARTICLE
Akram, M., Ahmed, A., Usmanghani, K., Hannan, A., Mohiuddin, E., & Asif, M. (2010) · Cited by 272
Anticancer agents from medicinal plants
Shoeb, M. (2008) · Bangladesh Journal of Pharmacology · doi:10.3329/bjp.v1i2.486 · Cited by 256
BEAULIEU, É., DEMEULE, M., GHITESCU, L., & BÉLIVEAU, R. (1997) · Biochemical Journal · doi:10.1042/bj3260539 · Cited by 253
Ward, A. B., Mir, H., Kapur, N., Gales, D. N., Carriere, P. P., & Singh, S. (2018) · World Journal of Surgical Oncology · doi:10.1186/s12957-018-1400-z · Cited by 245
The taxoids: paclitaxel and docetaxel
Gelmon, K. (1994) · The Lancet · doi:10.1016/s0140-6736(94)90754-4 · Cited by 243
Increased penetration of paclitaxel into the brain by inhibition of P-Glycoprotein.
Kemper, E. M., van Zandbergen, A. E., Cleypool, C. G. J., Mos, H. A., Boogerd, W. J., Beijnen, J. H., & van Tellingen, O. (2003) · PubMed · Cited by 243
Cabazitaxel: a novel second-line treatment for metastatic castration-resistant prostate cancer
Antonarakis, E., & Paller (2011) · Drug Design, Development and Therapy · doi:10.2147/dddt.s13029 · Cited by 225
Preclinical and Clinical Development of the Cyclin-Dependent Kinase Inhibitor Flavopiridol
Shapiro, G. I. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-040020 · Cited by 203
Boreddy, S. R., Pramanik, K. C., & Srivastava, S. K. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-1891 · Cited by 193
Zhu, L., & Xue, L. (2019) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.3727/096504018x15228018559434 · Cited by 192
Wu, H., Chen, L., Zhu, F., Han, X., Sun, L., & Chen, K. (2019) · Toxins · doi:10.3390/toxins11120731 · Cited by 192
Wang, F., Wang, L., Qu, C., Chen, L., Geng, Y., Cheng, C., Yu, S., Wang, D., Yang, L., Meng, Z., et al. (2021) · BMC Cancer · doi:10.1186/s12885-021-08158-z · Cited by 183
Cancer chemoprevention: scientific promise, clinical uncertainty
Sporn, M. B., & Liby, K. T. (2005) · Nature Clinical Practice Oncology · doi:10.1038/ncponc0319 · Cited by 176
Plants as a source of anticancer agents
Raj, Kaur, G., Kapoor, K., & Kaur, H. (2011) · Journal of natural product and plant resources · Cited by 167
Structural basis for inhibition of cyclin-dependent kinase 9 by flavopiridol
de Azevedo, W. F., Canduri, F., & da Silveira, N. J. F. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)00266-8 · Cited by 160
Naik, R. G., Kattige, S. L., Bhat, S. V., Alreja, B., de Souza, N. J., & Rupp, R. H. (1988) · Tetrahedron · doi:10.1016/s0040-4020(01)90352-7 · Cited by 158
Jiao, C., Chen, W., Tan, X., Liang, H., Li, J., Yun, H., He, C., Chen, J., Ma, X., Xie, Y., et al. (2019) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2019.112256 · Cited by 157
Natural Inhibitors of Carcinogenesis
Kinghorn, A. D., Su, B.-N., Jang, D. S., Chang, L. C., Lee, D., Gu, J.-Q., de Blanco, E. J. C., Pawlus, A. D., Lee, S. K., Park, E., et al. (2004) · Planta Medica · doi:10.1055/s-2004-827198 · Cited by 154
Antimitotic and tubulin-interacting properties of vinflunine, a novel fluorinated Vinca alkaloid
Kruczynski, A., Barret, J.-M. M., Etiévant, C., Colpaert, F. C., Fahy, J., & Hill, B. T. (1998) · Biochemical Pharmacology · doi:10.1016/s0006-2952(97)00505-4 · Cited by 149
Hetland, G., Tangen, J., Mahmood, F. A., Mirlashari, M. R., Nissen‐Meyer, L. S. H., Nentwich, I., Therkelsen, S. P., Tjønnfjord, G. E., & Johnson, E. (2020) · Nutrients · doi:10.3390/nu12051339 · Cited by 134
Tsai, Y., Xia, C., & Sun, Z. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.598555 · Cited by 133
Vinflunine: A New Microtubule Inhibitor Agent
Bennouna, J., Delord, J., Campone, M., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-2219 · Cited by 128
Update from Asia: Asian Studies on Cancer Chemoprevention
Yun, T.-K. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb08734.x · Cited by 125
Chen, M., Xiao, C., Jiang, W., Yang, W., Qin, Q., Tan, Q., Lian, B., Liang, Z.-J., & Wei, C. (2021) · Drug Design Development and Therapy · doi:10.2147/dddt.s269901 · Cited by 119
Wang, F., Mao, Y., You, Q., Hua, D., & Cai, D. (2015) · International Journal of Immunopathology and Pharmacology · doi:10.1177/0394632015598849 · Cited by 115
Significance of Medicinal Mushrooms in Integrative Oncology: A Narrative Review
Jeitler, M., Michalsen, A., Frings, D., Hübner, M., Fischer, J. M., Koppold, D. A., Murthy, V., & Keßler, C. S. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.580656 · Cited by 112
Piperine suppresses the Wnt/β-catenin pathway and has anti-cancer effects on colorectal cancer cells
de Almeida, G. C., Oliveira, L. F. S., Predes, D., Fokoue, H. H., Kuster, R. M., de Oliveira, F. L., Mendes, F. A., & Abreu, J. G. (2020) · Scientific Reports · doi:10.1038/s41598-020-68574-2 · Cited by 109
Kaplan, Ö., Tosun, N. G., Özgür, A., Tayhan, S. E., Bilgin, S., Türkekul, İ., & Gökçe, İ. (2021) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2021.102641 · Cited by 101
Current Uses of Mushrooms in Cancer Treatment and Their Anticancer Mechanisms
Park, H.-J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231810502 · Cited by 94
Preet, R., Mohapatra, P., Das, D., Satapathy, S. R., Choudhuri, T., Wyatt, M. D., & Kundu, C. N. (2012) · Carcinogenesis · doi:10.1093/carcin/bgs351 · Cited by 93
Pramanik, K. C., Fofaria, N. M., Gupta, P., Ranjan, A., Kim, S., & Srivastava, S. (2015) · Oncotarget · doi:10.18632/oncotarget.3427 · Cited by 90
Kongtawelert, P., Wudtiwai, B., Shwe, T. H., Pothacharoen, P., & Phitak, T. (2020) · Molecules · doi:10.3390/molecules25020252 · Cited by 86
Resveratrol Regulates Colorectal Cancer Cell Invasion by Modulation of Focal Adhesion Molecules
Buhrmann, C., Shayan, P., Goel, A., & Shakibaei, M. (2017) · Nutrients · doi:10.3390/nu9101073 · Cited by 84
Omacetaxine as an Anticancer Therapeutic: What is Old is New Again
Wetzler, M., & Segal, D. (2011) · Current Pharmaceutical Design · doi:10.2174/138161211795049778 · Cited by 81
Sağlam, A. S. Y., Alp, E., Elmazoğlu, Z., & Menevşe, S. (2015) · Human & Experimental Toxicology · doi:10.1177/0960327115595686 · Cited by 79
Phase 1 Clinical Trial of Trametes versicolor in Women with Breast Cancer
Torkelson, C. J., Sweet, E. S., Martzen, M. R., Sasagawa, M., Wenner, C. A., Gay, J., Putiri, A., & Standish, L. J. (2012) · ISRN Oncology · doi:10.5402/2012/251632 · Cited by 79
Guon, T. E., & Chung, H. S. (2016) · Oncology Letters · doi:10.3892/ol.2016.4247 · Cited by 79
Masraksa, W., Tanasawet, S., Hutamekalin, P., Wongtawatchai, T., & Sukketsiri, W. (2020) · Nutrition Research and Practice · doi:10.4162/nrp.2020.14.2.127 · Cited by 76
Sp, N., Kang, D. Y., Lee, J., Bae, S. W., & Jang, K. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094660 · Cited by 74
Arya, R. K., Singh, A., Yadav, N. K., Cheruvu, H. S., Hossain, Z. M., Meena, S., Maheshwari, S., Singh, A. K., Shahab, U., Sharma, C., et al. (2015) · Scientific Reports · doi:10.1038/srep18457 · Cited by 70
Twardowski, P. W., Kanaya, N., Frankel, P. H., Synold, T. W., Ruel, C., Pal, S. K., Junqueira, M., Prajapati, M., Moore, T., Tryon, P., et al. (2015) · Cancer · doi:10.1002/cncr.29421 · Cited by 69
Zheng, Q., Liu, Y., Liu, W., Ma, F., Zhou, Y., Chen, M., Chang, J., Wang, Y., Yang, G., & He, G. (2014) · Molecular Medicine Reports · doi:10.3892/mmr.2014.2175 · Cited by 68
Singla, R. K., De, R., Efferth, T., Mezzetti, B., Uddin, M. S., Sanusi, S., Ntie‐Kang, F., Wang, D., Schultz, F., Kharat, K. R., et al. (2022) · Phytomedicine · doi:10.1016/j.phymed.2022.154520 · Cited by 66
Nowakowski, P., Markiewicz‐Żukowska, R., Gromkowska-Kępka, K. J., Naliwajko, S. K., Moskwa, J., Bielecka, J., Grabia, M., Borawska, M. H., & Socha, K. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.111090 · Cited by 65
Peng, C.-C., Chen, K., Peng, R. Y., et al. (2006) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2006.07.009 · Cited by 62
Hussain, S.-R. A., Lucas, D. M., Johnson, A. J., Lin, T. S., Bakaletz, A. P., Dang, V., Viatchenko‐Karpinski, S., Ruppert, A. S., Byrd, J. C., Kuppusamy, P., et al. (2008) · Blood · doi:10.1182/blood-2007-10-115733 · Cited by 61
Self-citationSemeniuc, C. A., Socaciu, M., Socaci, S., Mureşan, V., Fogarasi, M., & Rotar, A. M. (2018) · Molecules · doi:10.3390/molecules23092261 · Cited by 61
Lycopene Protects against Smoking-Induced Lung Cancer by Inducing Base Excision Repair
Cheng, J., Miller, B., Balbuena, E., & Eroglu, A. (2020) · Antioxidants · doi:10.3390/antiox9070643 · Cited by 61
Erianin induces triple-negative breast cancer cells apoptosis by activating PI3K/Akt pathway
Xu, Y., Fang, R., Shao, J., & Cai, Z. (2021) · Bioscience Reports · doi:10.1042/bsr20210093 · Cited by 57
Lin, S., Zhuang, J., Zhu, L., & Jiang, Z. (2020) · Cancer Cell International · doi:10.1186/s12935-020-01293-w · Cited by 54
Hong, Y., Lee, J., Moon, H., Ryu, C. H., Seok, J., Jung, Y., Ryu, J., & Baek, S. J. (2021) · Cancers · doi:10.3390/cancers13123022 · Cited by 51
Kurzrock, R., Goel, S., Wheler, J., Hong, D., Fu, S., Rezai, K., Morgan‐Linnell, S. K., Urien, S., Mani, S., Chaudhary, I., et al. (2012) · Cancer · doi:10.1002/cncr.27647 · Cited by 50
Zhang, Y., Zhou, R., Liu, F., & Ng, T. B. (2021) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2021.01.149 · Cited by 50
Cao, H., Sethumadhavan, K., Cao, F., & Wang, T. T. Y. (2021) · Scientific Reports · doi:10.1038/s41598-021-84970-8 · Cited by 49
Kang, H. R., Moon, J. Y., Ediriweera, M. K., Song, Y. W., Cho, M., Kasiviswanathan, D., & Cho, S. K. (2020) · Food Science & Nutrition · doi:10.1002/fsn3.1495 · Cited by 48
Esnaashari, S. S., Muhammadnejad, S., Amanpour, S., & Amani, A. (2020) · AAPS PharmSciTech · doi:10.1208/s12249-020-01710-3 · Cited by 48
Aktepe, O. H., Şahin, T. K., Güner, G., Arık, Z., & Yalçın, Ş. (2020) · TURKISH JOURNAL OF MEDICAL SCIENCES · doi:10.3906/sag-2005-413 · Cited by 47
Discovery of anticancer drugs from antimalarial natural products: a MEDLINE literature review
Duffy, R., Wade, C. M., & Chang, R. Y. (2012) · Drug Discovery Today · doi:10.1016/j.drudis.2012.03.013 · Cited by 46
Gallic acid suppresses colon cancer proliferation by inhibiting SRC and EGFR phosphorylation
Lin, X., Wang, G., Liu, P., Han, L., Wang, T., Chen, K., & Gao, Y. (2021) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2021.10070 · Cited by 46
Zhang, B., Zhang, L., Chen, Y., Qiao, X. J., Zhao, S., Li, P., Liu, J., Wen, X., & Yang, J. (2021) · British Journal of Pharmacology · doi:10.1111/bph.15372 · Cited by 45
Onmaz, N. E., Yılmaz, D. D., Imre, K., Morar, A., Güngör, C., Yilmaz, S., Gündoğ, D. A., Dışhan, A., Herman, V., & GÜNGÖR, G. (2022) · Antibiotics · doi:10.3390/antibiotics11111466 · Cited by 42
Self-citationFadlalla, K., Watson, A. M., Yehualaeshet, T., Turner, T., & Samuel, T. (2011) · PubMed · Cited by 41
Zhang, C., Niu, Y., Wang, Z., Xu, X., Li, Y., Ma, L., Wang, J., & Yu, Y. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-04164-y · Cited by 40
Ingenol mebutate: an introduction.
Fallen, R. S., & Gooderham, M. (2012) · PubMed · Cited by 39
Li, J., Xiong, C., Xu, P., Luo, Q., & Zhang, R. (2020) · Bioengineered · doi:10.1080/21655979.2020.1868733 · Cited by 38
Exploration of the Antiplatelet Activity Profile of Betulinic Acid on Human Platelets
Tzakos, A. G., Kontogianni, V. G., Tsoumani, M. E., Kyriakou, E., Hwa, J., Rodrigues, F. A., & Tselepis, A. D. (2012) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf3006728 · Cited by 36
Jiang, X., Li, Y., Feng, J., Nabil, W. N. N., Wu, R., Lu, Y., Liu, H., Xi, Z., & Xu, H. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.598620 · Cited by 35
Li, M., Jin, S., Cao, Y., Xu, J., Zhu, S., & Li, Z. (2021) · Cancer Cell International · doi:10.1186/s12935-020-01711-z · Cited by 35
Shi, C.-J., Zheng, Y.-B., Pan, F., Zhang, F., Zhuang, P., & Fu, W.-M. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.708967 · Cited by 35
Czarnik-Kwaśniak, J., Kwaśniak, K., Kwasek, P., Świerzowska, E., Strojewska, A., & Tabarkiewicz, J. (2019) · Nutrients · doi:10.3390/nu12010096 · Cited by 33
Lv, L., Zhang, W., Li, T., Jiang, L., Lu, X., & Lin, J. (2020) · Oncology Reports · doi:10.3892/or.2020.7568 · Cited by 32
Xia, T., Liu, M., Huang, X., Zhu, Q., Liu, W., Chen, W., Zou, Y., Cai, Y., Huang, S., Chen, A., et al. (2020) · OncoTargets and Therapy · doi:10.2147/ott.s232137 · Cited by 32
Sargent, J. M., Elgie, A. W., Williamson, C. J., & Hill, B. T. (2003) · Anti-Cancer Drugs · doi:10.1097/00001813-200307000-00013 · Cited by 31
Zhang, Y., Li, Y., Sun, C., Chen, X., Han, L., Wang, T., Liu, J., Chen, X., & Zhao, D. (2021) · Cancers · doi:10.3390/cancers13164002 · Cited by 31
Hussein, N. A. E. M., El-Toukhy, M., Kazem, A. H., Ali, M. E.-S., Ahmad, M. A. E.-R., Ghazy, H. M. R., & El-Din, A. M. G. (2014) · Alexandria Journal of Medicine · doi:10.1016/j.ajme.2014.02.003 · Cited by 30
Kim, J., Yoo, J., Kim, J. S., Kim, S.-G., Park, J. E., Seok, Y. M., Son, J., & Kim, H. J. (2020) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2020/2584783 · Cited by 30
Rutckeviski, R., Corso, C. R., Román-Ochoa, Y., Cipriani, T. R., Centa, A., & Smiderle, F. R. (2021) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2021.118917 · Cited by 30
Thimmaraju, A., & Govindan, S. (2022) · Bioactive Carbohydrates and Dietary Fibre · doi:10.1016/j.bcdf.2022.100308 · Cited by 29
Tan, X., Chen, W., Jiao, C., Liang, H., Yun, H., He, C., Chen, J., Ma, X., & Xie, Y. (2019) · Food & Function · doi:10.1039/c9fo01230c · Cited by 28
Fekry, T., Salem, M. F., AbdEl-Aziz, A., Muawia, S., Naguib, Y. M., & Khalil, H. (2022) · International journal of medicinal mushrooms · doi:10.1615/intjmedmushrooms.2022045181 · Cited by 28
Zhu, A. X., Ready, N., Clark, J. W., Safran, H. P., Amato, A., Salem, N., Pace, S., He, X., Zvereva, N., Lynch, T. J., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1024 · Cited by 27
Luo, W., Sun, R., Chen, X., Ju, L., Jiang, J., He, Y., Shi, S., & Wen, H. (2021) · OncoTargets and Therapy · doi:10.2147/ott.s278268 · Cited by 27
Cen, K., Chen, M., He, M., Li, Z., Song, Y., Liu, P., Jiang, Q., Xu, S., Jia, Y., & Shen, P. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.826716 · Cited by 26
Mondal, A., Banerjee, D., Majumder, R., Maity, T. K., & Khowala, S. (2016) · Pharmaceutical Biology · doi:10.3109/13880209.2016.1168854 · Cited by 25
Yoon, S. Y., Lindroth, A. M., Kwon, S., Park, S.-J., & Park, Y. J. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113491 · Cited by 25
Novel Strategies for Plant-Derived Anticancer Agents
Kinghorn, A. D., Farnsworth, N. R., Beecher, C., Soejarto, D. D., Cordell, G., Jm, P., Wall, M. E., Wani, M. C., Brown, D., O'neill, M. M., et al. (1995) · Pharmaceutical Biology · doi:10.3109/13880209509067087 · Cited by 24
Bishayee, A., & Mandal, A. (2014) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2014.01.002 · Cited by 23
Haque, M. A., Reza, A. S. M. A., Nasrin, S., & Rahman, M. A. (2020) · Integrative Cancer Therapies · doi:10.1177/1534735420969809 · Cited by 23
Zhang, D.-F., Yang, Z., Chen, J., Jin, X., Qiu, Y., Chen, X., Shi, H.-Y., Liu, Z., Wang, M., Liang, G., et al. (2021) · BMC Complementary Medicine and Therapies · doi:10.1186/s12906-021-03369-0 · Cited by 23
Lau, M., Chua, K. H., Sabaratnam, V., & Kuppusamy, U. R. (2020) · Biotechnology and Applied Biochemistry · doi:10.1002/bab.2013 · Cited by 22
Haasler, L., Kondadi, A. K., Tsigaras, T., von Montfort, C., Gräf, P., Stahl, W., & Brenneisen, P. (2021) · Archives of Toxicology · doi:10.1007/s00204-021-02987-4 · Cited by 21
Sadowska, A. J., Zapora, E., Sawicka, D., Niemirowicz-Laskowska, K., Surażyński, A., Sułkowska‐Ziaja, K., Kała, K., Stocki, M., Wołkowycki, M., Bakier, S., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21103447 · Cited by 19
Isoquinoline alkaloids from Hylomecon japonica and their potential anti-breast cancer activities
Cao, Z., Zhu, S., Xue, Z., Zhang, F., Zhang, L., Zhang, Y., Guo, Y., Zhan, G., Zhang, X., & Guo, Z. (2022) · Phytochemistry · doi:10.1016/j.phytochem.2022.113321 · Cited by 19
Dai, S., Liu, Y., Zhao, F., Wang, H., Shao, T., Xu, Z., Shou, L., Chen, S., Zhang, G.-C.-X., & Shu, Q. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113628 · Cited by 18
Agaricus blazei extract (FA‑2‑b‑β) induces apoptosis in chronic myeloid leukemia cells
Sun, Y., Cheng, M.-X., Li, D., Yang, K., Ma, Z., Yu, S.-R., Yan, P., Bai, K.-T., Zhu, X., & Zhang, Q. (2020) · Oncology Letters · doi:10.3892/ol.2020.12133 · Cited by 17
Kong, B. H., Teoh, K., Tan, N. H., Tan, C.-S., Ng, S. T., & Fung, S. Y. (2020) · PeerJ · doi:10.7717/peerj.9650 · Cited by 16
Cheng, A.-Y., Chien, Y., Lee, H.-C., Hsieh, Y., & Yu, Y. (2020) · Molecules · doi:10.3390/molecules25163585 · Cited by 15
Vinflunine in the treatment of advanced bladder cancer
Mamtani, R., & Vaughn, D. J. (2010) · Expert Review of Anticancer Therapy · doi:10.1586/era.10.196 · Cited by 14
Novel compounds in the treatment of lung cancer: current and developing therapeutic agents
Bao, R., & Chan (2011) · Journal of Experimental Pharmacology · doi:10.2147/jep.s7804 · Cited by 12
Kim, J., Yoo, J., Park, J.-S., Kim, J., Kim, S.-G., Seok, Y.-J., Son, J., & Kim, H. (2021) · Molecular Medicine Reports · doi:10.3892/mmr.2021.12254 · Cited by 10
Cui, A., Li, X., Ma, X., Song, Z.-G., Wang, X., Wang, C., & Xia, Y. (2023) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2023.116749 · Cited by 10
Ma, J., Hui, L., Song, N., Zhang, X., Qu, D., Sang, C., & Li, H. (2021) · Pharmacognosy Magazine · doi:10.4103/pm.pm_251_20 · Cited by 9
Biopharmaceutical Drugs from Natural Sources
Newman, D. J., Cragg, G. M. L., & O’Keefe, B. R. (2005) · Wiley eBooks · doi:10.1002/9783527620982.ch19 · Cited by 5
Cui, A., Li, X., Ma, X., Wang, X., Liu, C., Song, Z.-G., Pan, F., Xia, Y., & Li, C. (2021) · Research Square · doi:10.21203/rs.3.rs-705930/v1 · Cited by 4
Cited by
Hernández-Rangel, A. E., Cabrera-Licona, A., Hernandez-Fuentes, G. A., Beas-Guzmán, O. F., Martínez-Martínez, F. J., Alcalá-Pérez, M. A., Montes-Galindo, D. A., Rodriguez-Sanchez, I. P., Martinez-Fierro, M. L., Casarez-Price, J. C., et al. (2024) · Biomedicines · doi:10.3390/biomedicines12081804 · Cited by 7
Lakshmanan, J., Jaganathan, V. L., Zhang, B., Werner, G., Allen, T. S., Schultz, D. J., Klinge, C. M., & Harbrecht, B. G. (2025) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/0118715206327789241008162423 · Cited by 5
Metadata
- Authors
- Asma, S. T., Acaroz, U., Imre, K., Morar, A., Shah, S. R. A., Hussain, S. Z., Arslan-Acaroz, D., Demirbas, H., Hajrulai-Musliu, Z., Istanbullugil, F. R., Soleimanzadeh, A., Morozov, D., Zhu, K., Herman, V., Ayad, A., Athanassiou, C., & Ince, S.
- Venue
- Cancers
- Publisher
- MDPI AG
- Published
- 2022-12-15
- Volume
- 14
- Issue
- 24
- Pages
- 6203
- ISSN
- 2072-6694 (ISSN-L)
- OpenAlex
- W4312140587
- Cited by
- 378
- References
- 126
- FWCI
- 29.97
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.